Patient Profile: Burmese-speaking patient with limited engagement history and A1c of 13.8%
Medications:
- Trulicity
- Metformin ER
- Atorvastatin
Northwind Actions: Culturally sensitive outreach and coordination with clinic care enabled optimal care and therapy simplification
Measures Taken:
- RN and clinic collaborated to connect with patient
- Discontinued Lantus (brand name Insulin injection) after improvement
Clinical Results:
- A1c trend: 5.5% Reduction in 3 months
- In December 2023, the patient engaged with the clinic and enrolled in the program with an A1c of 13.8%. Throughout her engagement, she has reduced her A1c to 5.3% and was able to discontinue insulin therapy.
- Patient now has normal A1c
- BP controlled without medication